A systematic approach to subgroup analyses in a smoking cessation trial

References

• Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Statist Med 2002;21:2917–2930
   PubMed Web of Science ®Google Scholar
• Hamburg MA, Collins FS. The path to personalized medicine. New Eng J Med 2010;363:301–304
   PubMed Web of Science ®Google Scholar
• Petticrew M, Tugwell P, Kristjansson E, Oliver S, Ueffing E, Welch V. Damned if you do, damned if you don’t: subgroup analysis and equity. J Epidemiol Community Health 2012;66:95–98
   PubMed Web of Science ®Google Scholar
• Rothwell PM. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. The Lancet 2005;365:176–186
   PubMed Web of Science ®Google Scholar
• Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, Bala MM, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ 2012;344:e1553
   PubMed Web of Science ®Google Scholar
• Wallace ML, Frank E, Kraemer HC. A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials. JAMA Psychiatry 2013;70:1241--1247
   PubMed Web of Science ®Google Scholar
• Akaike H. Information theory and an extension the maximum likelihood principle. In: Petrov BN, Csaki F, eds. Second international symposium on information theory. Budapest: Academiai Kiado; 1973:267–281
   Google Scholar
• Burnham KP, Anderson DR. Model selection and multi-model inference. New York: Springer-Verlag; 2002
   Google Scholar
• Bozdogan H. Akaike’s information criterion and recent developments in information complexity. J Math Psychol 2000;44:62–91
   PubMed Web of Science ®Google Scholar
• Monuteaux MC, Spencer TJ, Faraone SV, Wilson AM, Biederman J. A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2007;68:1094–1101
   PubMed Web of Science ®Google Scholar
• Golubchik P, Sever J, Weizman A. Influence of methylphenidate treatment on smoking behavior in adolescent girls with attention-deficit/hyperactivity and borderline personality disorders. Clin Neuropharmacol 2009;32:239–242
   PubMed Web of Science ®Google Scholar
• Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, Covey LS, Croghan IT, et al. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2010;71:1680--1688
   PubMed Web of Science ®Google Scholar
• Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 1995;7:373–378
   PubMedGoogle Scholar
• Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 1998;31:533–544
   PubMed Web of Science ®Google Scholar
• Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meck WH, Rose JE, et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) 1996;123:55–63
   PubMed Web of Science ®Google Scholar
• Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003;5:13–25
   PubMed Web of Science ®Google Scholar
• Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991;86:1119–1127
   PubMedGoogle Scholar
• Dupaul GJ, Power TJ, Anastopoulos AD. ADHD rating scale – IV: checklists, norms, and clinical interpretation. New York: Guilford Press; 1998
   Google Scholar
• Beck AT, Steer RA, Brown GK. Beck Depression Inventory – II. San Antonio, TX: The Psychological Corporation, Harcourt Brace & Company; 1996
   Google Scholar
• Beck AT, Steer RA. Beck Anxiety Inventory: manual. San Antonio, TX: The Psychological Corporation, Harcourt Brace & Company; 1990
   Google Scholar
• Golden R, Henley S, White H, Kashner T. New directions in information matrix testing: Eigenspectrum tests. In: Chen X, Swanson NR, eds. Recent advances and future directions in causality, prediction, and specification analysis. New York: Springer; 2013:145--177
   Google Scholar
• Hilbe JM. Logistic regression models. New York: Chapman and Hall; 2009
   Google Scholar
• Nunes EV, Covey LS, Brigham G, Hu MC, Levin FR, Somoza EC, Winhusen TM. Treating nicotine dependence by targeting attention-deficit/hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response. J Clin Psychiatry 2013;74:983–990
   PubMed Web of Science ®Google Scholar
• White HL. Maximum likelihood estimation of misspecified models. Econometrica 1982;50:1–25
   Web of Science ®Google Scholar
• Claeskens G, Hjort N. Model selection and model averaging. New York: Cambridge University Press; 2009
   Google Scholar
• Hastie T, Tibshirani R, Friedman J. The elements of statistical learning. New York: Springer-Verlag; 2001
   Google Scholar
• Hosmer DW, Lemeshow S. Applied logistic regression, 2nd ed. New York: John Wiley & Sons; 2000
   Google Scholar
• Guideline on the investigation of subgroups in confirmatory clinical trials. European Medicines Agency; 2104. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/02/WC500160523.pdf
   Google Scholar
• Golden R. Discrepancy Risk Model Selection Test theory for comparing possibly misspecified or nonnested models. Psychometrika 2003;68:229–249
   Web of Science ®Google Scholar
• Garside MJ. The best subset in multiple regression analysis. Appl Statist 1965;14:195–200
   Google Scholar
• Furnival GM. All possible regressions with less computation. Technometrics 1971;13:403–408
   Web of Science ®Google Scholar
• Furnival G, Wilson R. Regression by leaps and bounds. Technometrics 1974;16:499–511
   Web of Science ®Google Scholar
• Hosmer DW, Jovanovic B, Lemeshow S. Best subsets logistic regression. Biometrics 1989;45:1265–1270
   Web of Science ®Google Scholar
• Miller A. Subset selection in regression. London: Chapman and Hall; 2002
   Google Scholar
• Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Internal Med 2009;151:206–209
   PubMed Web of Science ®Google Scholar
• Conway PH, Clancy C. Comparative-effectiveness research – implications of the Federal Coordinating Council’s report. New Eng J Med 2009;361:328–330
   PubMed Web of Science ®Google Scholar
• Covey LS, Hu MC, Winhusen T, Weissman J, Berlin I, Nunes EV. OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences. Drug Alcohol Depend 2010;110:156–159
   PubMed Web of Science ®Google Scholar
• Covey LS, Hu MC, Weissman J, Croghan I, Adler L, Winhusen T. Divergence by ADHD subtype in smoking cessation response to OROS-methylphenidate. Nicotine Tob Res 2011;13:1003–1008
   PubMed Web of Science ®Google Scholar
• Covey LS, Hu MC, Green CA, Brigham G, Hurt RD, Adler L, Winhusen T. An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with attention deficit/hyperactivity disorder. Am J Drug Alcohol Abuse 2011;37:392–399
   PubMed Web of Science ®Google Scholar
• Berlin I, Hu MC, Covey LS, Winhusen T. Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD. Drug Alcohol Depend 2012;124:268–273
   PubMed Web of Science ®Google Scholar
• Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consulting Clin Psychol 2004;72:1144–1156
   PubMed Web of Science ®Google Scholar
• Buitelaar JK, Kooij JJ, Ramos-Quiroga JA, Dejonckheere J, Casas M, van Oene JC, Schauble B, et al. Predictors of treatment outcome in adults with ADHD treated with OROS(R) methylphenidate. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:554–560
   PubMed Web of Science ®Google Scholar
• Hernandez AV, Boersma E, Murray GD, Habbema JD, Steyerberg EW. Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading? Am Heart J 2006;151:257–264
   PubMed Web of Science ®Google Scholar
• Bagley SC, White H, Golomb BA. Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. J Clin Epidemiol 2001;54:979–985
   PubMed Web of Science ®Google Scholar